Your browser doesn't support javascript.
loading
Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
Peter, Megan E; Markley, Brandon; DeClercq, Josh; Choi, Leena; Givens, Gabrielle; Zuckerman, Autumn D; Banks, Aimee.
Affiliation
  • Peter ME; Vanderbilt Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN.
  • Markley B; Vanderbilt Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN.
  • DeClercq J; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
  • Choi L; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
  • Givens G; Lipscomb University College of Pharmacy, Nashville, TN.
  • Zuckerman AD; Vanderbilt Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN.
  • Banks A; Vanderbilt Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN.
J Manag Care Spec Pharm ; 27(2): 256-262, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33506731

Full text: 1 Database: MEDLINE Main subject: Pharmaceutical Services / 4-Aminopyridine / Health Services Accessibility / Health Systems Plans / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: J Manag Care Spec Pharm Year: 2021 Type: Article Affiliation country: Tunisia

Full text: 1 Database: MEDLINE Main subject: Pharmaceutical Services / 4-Aminopyridine / Health Services Accessibility / Health Systems Plans / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: J Manag Care Spec Pharm Year: 2021 Type: Article Affiliation country: Tunisia